Salarius Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Salarius Pharmaceuticals (SLRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Salarius Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Salarius Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Salarius Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $14k | 7.1k | 2.00 |
2024-09-30 | $390 | 260 | 1.50 |
2024-06-30 | $282 | 113 | 2.50 |